Clinical Potential of Matrix Metalloprotease Inhibitors in Cancer Therapy

By Heath E.I.  

Drugs, Vol. 59, Iss. 5, 2000-05 ,pp. : 1043-1055

Adis International

Access to resources Recommend Favorite

Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain

By Dev Rishabh   Srivastava Punit Kumar   Iyer Jitesh P   Dastidar Sunanda G   Ray Abhijit  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 4, 2010-04 ,pp. : 455-468

Informa Healthcare

Access to resources Recommend Favorite

The Crosstalk Between the Matrix Metalloprotease System and the Chemokine Network in Acute Myeloid Leukemia

By  

Current Medicinal Chemistry, Vol. 17, Iss. 36, 2010-12 ,pp. : 4448-4461

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and degradation of endothelin-1

By D'Orléans-Juste P   Plante M   Honoré J C   Carrier E   Labonté J  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 6, 2003-06 ,pp. : 503-510

NRC Research Press

Access to resources Recommend Favorite

Enhanced hit-to-lead process using bioanalogous lead evolution and chemogenomics: application in designing selective matrix metalloprotease inhibitors

By Papp Ákos   Szommer Tamás   Barna László   Gyimesi Gergely   Ferdinandy Péter   Spadoni Cesare   Darvas Ferenc   Fujita Toshio   Ürge László   Dormán György  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 5, 2007-05 ,pp. : 707-723

Informa Healthcare

Access to resources Recommend Favorite